Document Detail


Activation of poly(ADP-ribose) polymerase in circulating leukocytes during myocardial infarction.
MedLine Citation:
PMID:  14770035     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Myocardial ischemia-reperfusion can lead to increased oxidative stress both locally and in circulating leukocytes. Oxidant-mediated DNA single strand breaks are known to activate the nuclear enzyme poly(ADP-ribose) polymerase (PARP) in various forms of shock, inflammation, and ischemia-reperfusion injury. The aim of the current study was to investigate whether a local insult such as myocardial ischemia-reperfusion is sufficient to lead to activation of PARP in circulating leukocytes. In anesthetized rats myocardial ischemia-reperfusion was induced by transient ligation of the left anterior descending coronary artery. There was a marked increase in poly(ADP-ribosyl)ation of proteins in homogenates of leukocytes isolated from rats at the end of the reperfusion period. Poly(ADP-ribosyl)ation was inhibited by administration of the pharmacologic PARP inhibitor INO-1001 (30 mg/kg) to the rats. We conclude that local insults, such as myocardial reperfusion injury, are sufficient to activate PARP in circulating leukocytes. PARP activation in circulating cells may mediate certain systemic effects of local ischemia-reperfusion injury such as inflammatory mediator production and remote organ injury.
Authors:
Kanneganti G K Murthy; Chun-Yang Xiao; Jon G Mabley; Min Chen; Csaba Szabó
Related Documents :
8380245 - Leukocyte depletion in a neonatal model of cardiac surgery.
12895455 - Neutrophils do not contribute to infarction, oxidative stress, and no synthase activity...
24533675 - Ranolazine for the suppression of ventricular arrhythmia: a case series.
21057315 - Cardiopulmonary effects of low-dose arginine vasopressin in ovine acute lung injury.
18667735 - Preoperative use of angiotensin-converting enzyme inhibitors/angiotensin receptor block...
15277725 - Chymase-derived angiotensin ii and arrhythmias after myocardial infarction.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Shock (Augusta, Ga.)     Volume:  21     ISSN:  1073-2322     ISO Abbreviation:  Shock     Publication Date:  2004 Mar 
Date Detail:
Created Date:  2004-02-10     Completed Date:  2004-10-19     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  9421564     Medline TA:  Shock     Country:  United States    
Other Details:
Languages:  eng     Pagination:  230-4     Citation Subset:  IM    
Affiliation:
Inotek Pharmaceuticals Corporation, Beverly, MA 01915, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Blotting, Western
Cell Line, Tumor
DNA / metabolism
DNA Damage
Enzyme Activation
Enzyme Inhibitors / pharmacology
Epithelial Cells / metabolism
Humans
Hydrogen Peroxide / pharmacology
Indoles / pharmacology
Inflammation
Leukocytes / enzymology*,  metabolism
Male
Myocardial Infarction / metabolism*
Myocardium / enzymology,  pathology
Poly(ADP-ribose) Polymerases / blood,  metabolism*
Precipitin Tests
Rats
Rats, Wistar
Reperfusion Injury
Time Factors
Grant Support
ID/Acronym/Agency:
R01HL59266/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Enzyme Inhibitors; 0/INO 1001; 0/Indoles; 7722-84-1/Hydrogen Peroxide; 9007-49-2/DNA; EC 2.4.2.30/Poly(ADP-ribose) Polymerases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of drotrecogin alfa (activated) in human endotoxemia.
Next Document:  Improving microcirculation is more effective than substitution of red blood cells to correct metabol...